A brand new imaging method might doubtlessly assist hundreds of males keep away from invasive assessments to examine if they’ve prostate most cancers, a charity has mentioned.
A examine revealed within the journal Radiology discovered a brand new kind of MRI scan might assist docs rule out prostate most cancers extra usually, doubtlessly saving hundreds of males from present process pointless biopsies.
Using the VERDICT MRI scan alongside customary imaging strategies was discovered to be considerably higher at figuring out males who shouldn’t have prostate most cancers, in line with researchers at University College London.
Prostate Cancer UK, which funded the examine alongside Movember, mentioned it means hundreds of males might safely keep away from having a biopsy to check for prostate most cancers.
Biopsies carry a sure threat, so the discovering could possibly be vital for future apply within the NHS.
Prostate Cancer UK mentioned if the brand new method is deployed it might doubtlessly scale back the variety of pointless biopsies by 90%.
Dr Matthew Hobbs, director of analysis at Prostate Cancer UK, mentioned: “It’s uncommon to see such an enormous enchancment on present apply, each by way of accuracy and driving down harms brought on by testing.
“These results are a massive leap forward for an exciting new test that could spare thousands of men each year unnecessary anxiety and pain.”
Experts mentioned that the brand new method could possibly be carried out utilizing customary MRI scanners, which implies that it might be “straightforward” to deploy.
Professor Shonit Punwani, lead investigator of the trial, mentioned: “These results show that VERDICT could allow men to know, with confidence, that they do not have prostate cancer and do not need a biopsy.
“This new method requires no new tools – it may be been finished on MRI scanners already in use and may finally be doable on all customary 3T scanners, so could be comparatively simple to roll out into medical apply throughout the UK.
“It potentially has the added benefit of reducing the cost of diagnosing prostate cancer to the NHS, which is hugely important given the additional strain on the system caused by the pandemic.
“Our subsequent step is to make use of VERDICT MRI in a good greater medical trial throughout a number of hospital websites. If profitable, the trial ought to present the proof wanted to alter apply within the NHS within the close to future.”